Both in Pharmaceuticals
IDEAYA Biosciences vs Viridian Therapeutics
Over the past year IDYA returned +1.1% and VRDN returned +4.3%; their daily moves had a correlation of 0.21.
IDYA +1.1% VRDN +4.3%Growth of $1, one year, split-adjusted
| Metric | IDYA | VRDN |
|---|---|---|
| Price | $31.96 | $24.67 |
| Market cap | $3.08B | $2.79B |
| Today | −2.83% | −0.52% |
| 1 month | −15.5% | +29.9% |
| 6 months | +13.4% | +83.8% |
| Year to date | −7.5% | −20.7% |
| 1 year | −0.7% | +7.2% |
| Revenue growth (YoY) | — | +278.7% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −1269.6% | −39726.8% |
| P/E (TTM) | — | — |
| Price / sales | 13.2× | 39.3× |
| Net cash | $829.0M | $625.7M |
| Dividend yield | — | — |
| Volatility (60d) | 37.3% | 48.2% |
| Short % of float | 10.4% | 18.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).